For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
The interventional approach to treat peripheral artery occlusive disease (PAOD) as a treatment of choice is gaining continuous acceptance. SeQuent® Please OTW offers a targeted, polymer-free and homogenous drug delivery which was enhanced for larger balloons sizes. This innovative product is the result of our sustained research and development for significant improvements in peripheral and coronary balloon angioplasty.
B. Braun has more than 10 years experience and leadership in drug coated balloon angioplasty and developed an outstanding coating technology for the use in peripheral arteries. With our continued research and product development in interventional drug delivery we achieved a new milestone in interventional radiology.
Several randomised trials (Thunder, Fempac, Pacifier) have demonstrated safety and efficacy of Paclitaxel coated balloons in peripheral arteries.
For more detail: https://www.bbraun.com/en/products/b/sequent-please-otw.html